Cardiovascular outcomes of vildagliptin in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke

Cardiovascular outcomes of vildagliptin in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke

Abstract Aims/Introduction The cardiovascular (CV) outcomes of vildagliptin – a dipeptidyl peptidase‐4 inhibitor – in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke are unclear. Materials and Methods We analyzed data from the Taiwan National Health Insu...

Full description

Bibliographic Details
Main Authors: Dong‐Yi Chen, Yan‐Rong Li, Chun‐Tai Mao, Chi‐Nan Tseng, I‐Chang Hsieh, Ming‐Jui Hung, Pao‐Hsien Chu, Chao‐Hung Wang, Ming‐Shien Wen, Wen‐Jin Cherng, Tien‐Hsing Chen
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Diabetes Investigation
Subjects:
Cardiovascular outcome
Type 2 diabetes mellitus
Vildagliptin
Online Access:https://doi.org/10.1111/jdi.13078

Internet

https://doi.org/10.1111/jdi.13078

Similar Items